Sign In
11% Fall In Regulatory Violations In Indian Pharma In 2024: Report
Regulatory violations in India’s pharma sector fell 11pc in 2024
USFDA Pulls Up Jagsonpal Pharma For Lapses At API
New Drugs To Tackle AMR, Kala-Azar Developed In India
Indian Develops Innovative Anti-Ageing Formulation
Vedanta Demerger Receives Nod From Shareholders, Creditors
Latest News
Virender Sehwag warns 14-year-old batting sensation Vaibhav Suryavanshi — here’s why
Shriram Finance revises FD interest rates effective May 2
Prestige Hotel Ventures Limited files DRHP with SEBI
LIC HF cuts lending rates by 25 bps making home loans cheaper
Trending Articles
BMRCL to Begin Red Line Work, Connecting Hebbal and Sarjapur
iPhone SE is out—Say hello to the iPhone 17e: Apple’s budget line gets a refresh
GTA 6: Price, Release Timeline, Map, Trailer 2, and Everything We Know So Far
Invest in LIC Saral Pension Plan to Get Lifetime Rs 12K Monthly Pension
Aurobindo Pharma to commence Europe Supplies From China Plant
India’s Pharma Exports Potential To Reach $350 Bn
High Levels Of Industrial Chemical Found In Fentanyl Drug
Neurobion’s Campaign To Show Benefits Of Vitamin-B
Q3 Results 2025 Highlights: Gland Pharma's revenue drop by 10% to Rs 1,384 crore
Cipla to infuse ZAR 900 mn in South African arm
